Zydus launches cancer biosimilar nivolumab at steep discount Vimal Sharma 2 months ago The launch follows a Delhi High Court nod allowing sales of the cancer drug biosimilar ahead of patent expiry in May 2026. Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X
